U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis
2023-11-01 07:29
Analysis-FTC settlement could shelter Amgen from US price cuts, taxes
By Deena Beasley The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of Horizon Therapeutics
2023-09-05 18:19
Amgen settles with the FTC over $28 billion deal
The Federal Trade Commission will allow pharmaceutical giant Amgen to move ahead with its acquisition of Horizon Therapeutics, averting a trial set for September.
2023-09-02 00:17
Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal
By Manas Mishra and David Shepardson (Reuters) -The U.S. Federal Trade Commission has allowed Amgen to go ahead with its
2023-09-01 23:00
US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics
The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics,
2023-08-26 23:51
California, other states join FTC bid to block Amgen deal
The states of California, Minnesota and Wisconsin on Thursday joined a Federal Trade Commission lawsuit to stop Amgen's
2023-06-23 04:47
FTC effort to stop Amgen's Horizon takeover faces uphill fight
By Diane Bartz WASHINGTON The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen
2023-05-18 23:19
US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics
By Diane Bartz and Leroy Leo WASHINGTON (Reuters) -The U.S. Federal Trade Commission said on Tuesday it has filed a
2023-05-17 05:26
FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC
Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen's acquisition of Horizon
2023-05-16 22:59
FTC to block Amgen's deal to acquire Horizon Therapeutics - source
The US Federal Trade Commission (FTC) is expected to file a lawsuit as early as Tuesday to block
2023-05-16 09:53